Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Fresenius Kabi USA, LLC recalls Glycopyrrolate Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of Particulate Matter: Hair was found in product
Products
  • Glycopyrrolate Injection
Where it was sold

Nationwide within in the USA

Nationwide

Units affected
59,425 vials
About this recall
Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07